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Summary 
The analytical characteristics of aptamers are comparable with those of antibodies for the development of biosensor 
technology. However, aptamers offer some crucial advantages over antibodies such as selection capability for a 
variety of targets, easy synthesis, improved reproducibility and stability, simple modification for immobilization to 
solid supports and enhanced selectivity. This article reviews aptamer technology as well as aptamer-based assay 
configurations and goes on to explore reported applications in electrochemical aptasensors. 
 
 
I. Introduction 
Biosensor technology holds a great promise for the 
healthcare market, the security sector, the food industry, 
environmental and veterinary diagnostic; harnessing the 
specificity and sensitivity of biological-based assays 
packaged into portable and low cost devices which allow 
for rapid analysis of complex samples in out-of-laboratory 
environments. However the application of biosensors lags 
far behind the fundamental research; the challenges facing 
this basic technology are associated with sensitive 
detection of specific molecules in samples, stability issues, 
quality assurance, instrumentation design and cost 
considerations (Velasco-Garcia and Tottram, 2003). 
The main biological sensing materials used in 
biosensor development are the couples enzyme/substrate 
and antibody/antigen. These are limited by temperature, 
sensitivity, stability, batch-to-batch variation, large size 
and difficulty in production. Recent advances and 
developments in the aptamer area offer a powerful 
alternative approach involving the use of small RNA or 
DNA molecules that bind to specific targets with very high 
affinity and specificity. Aptamer receptors are a novel 
entity of undeniable potential in analytical applications 
and can complement or substitute antibodies or offer 
applications where the later are not compatible (Tombelli 
et al, 2005, 2007). 
Despite the fact that development of aptasensors has 
been boosted by using optical and acoustic transducers, 
this review summarizes the recent developments in the 
design of electrochemical aptamer-based affinity sensors. 
In comparison with other detection systems, the 
electrochemical detection combines a high sensitivity, 
direct electronic signal production, fast response, 
robustness, low cost, the possibility of miniaturization and 
simultaneous multianalyte detection. 
 
II. Aptamers 
As aptamers approach 20 years since they were 
originally described (Ellington and Szostak, 1990; Tuerk 
and Gold, 1990), they are currently receiving a wider 
recognition in the literature as research reagents, 
inhibitors, imaging or diagnostic agents (Luzi et al, 2003; 
Hamula et al, 2006). Aptamers are short, single stranded 
oligonucleotides, which inherently adopt stable three 
dimensional sequence-dependent structures. This intrinsic 
property makes them efficient binding molecules, capable 
of binding to an array of molecular targets ranging from 
small ions and organic molecules to large glycoproteins 
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and mucins (Ferreira et al, 2006). Aptamers are a novel 
and particularly interesting targeting modality, with the 
ability to bind to a variety of targets including proteins, 
peptides, enzymes, antibodies and cell surface receptors, 
as well as small molecules ranging from glucose and 
caffeine, to steroids to TNT. Aptamers are single stranded 
oligonucleotides that vary in size between 25-90 bases 
long and adopt complex secondary and tertiary structures, 
which facilitate specific interactions with other molecules. 
They are derived from vast combinatorial libraries through 
selective targeting and competitive binding. There are two 
different configurations of aptamers: (i) linear and (ii) 
molecular beacon. Aptamers with a linear configuration 
maintain in certain physicochemical conditions a typical 3-
D conformation with specific binding sites for the target 
molecule. On the other hand aptamers with a molecular 
beacon configuration initially form a loop that changes 
conformation following binding to the analyte of interest. 
Aptamers offer unique benefits compared to other 
targeting agents; not only they bind specific ligands with 
high affinity and selectivity, but aptamers can be easily 
selected using in vitro techniques and are chemically 
synthesized, overcoming the use of animal for their 
production. In comparison to antibodies, aptamers are 
purified to a very high degree of purity, which eliminates 
the batch-to-batch variation found in antibodies. Aptamers 
have higher temperature stability (stable at room 
temperature) and because of their small size, denser 
receptor layers could be generated. The animal-free 
production of aptamers is especially advantageous in cases 
where the immune response can fail when the target 
molecule (e.g. a protein) has a structure similar to 
endogenous proteins or when the antigen consists of toxic 
or non-immunogenic compounds. Aptamers are relatively 
stable under a wide range of buffer conditions and 
resistant to chemical degradation, although, due to their 
DNA or RNA constitution, they are sensitive to hydrolytic 
digestion by nucleases. Aptamers have been modified into 
nuclease-resistant moieties by modification of the ribose 
ring at the 2’-position or by the specific modification of 
the pyrimidine nucleotide (Pieken et al, 1991; Heidenreich 
and Eckstein, 1992; Kusser, 2000). It is also possible to 
chemically modify aptamers to facilitate covalent 
conjugation to reporters and nanoparticles with 5’ or 3’ 
amino, biotin or thiol groups. These characteristics make 
them extremely attractive as alternatives to antibodies and 
peptides for use in assays, or as diagnostic agents. 
 
A. The SELEX process 
Aptamers are typically isolated from combinatorial 
libraries by a process of in vitro evolution, termed SELEX 
(Systematic Evolution of Ligands by EXponential 
enrichment). This procedure is an in vitro evolutionary 
selection process that allows the isolation of aptamer(s), 
with unique binding properties, from a large library of 
oligonucleotides through iterative cycles of (i) interaction 
of a large library of aptamers with the target molecule, (ii) 
separation of bound from unbound aptamer species, (iii) 
elution of bound aptamers and (iv) PCR amplification of 
the binding aptamers for further selection rounds (Figure 
1 for an example of the process). 
 
 
Library is incubated with target
under desired selection conditions
Unbound or non-specifically 
bound species are washed 
away and discarded
Aptamers are interacting
with and separated from
target using various separation
techniques, including affinity
chromatography columns,
magnetic bids or membranes
Desalted aptamers 
are lyophilised and 
PCR reagents added 
for amplification
Amplified aptamers 
are used in successive 
selection rounds
Aptamers from the 
final selection round 
are double stranded 
and cloned in E. coli
Clones are sequenced 
for identification of 
high binding aptamer 
species to be used 
subsequently for 
further development
Bound aptamers are 
eluted from their 
target using high 
salt or chaotropic
agents and desalted 
for further PCR 
amplification steps
Positive clones are analysed
 
 
Figure 1. The SELEX process. 
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An aptamer library usually consists of a variable 
region (20-40 nucleotides) flanked by known primer 
sequences on either end for the amplification during the 
SELEX procedure. The variable region makes up to 1015 
different sequences which, combined with the innate 
ability of oligonucleotides to form stable sequence-
dependent structures, provide an array of molecular shapes 
available for the selection process (Khan and Missailidis, 
2008). In the selection steps, the library is incubated with 
the immobilised target. Unbound or weak-binding species 
are removed and bound aptamers are eluted using high 
salt, temperature, chaotropic agents or other such 
conditions that would affect molecular structure or disrupt 
molecular interactions. Eluted aptamers are subsequently 
amplified by PCR (DNA) or reverse-transcription PCR 
(RT PCR) using primers complementary to the flanking 
sequences in the aptamer library. The enriched pool of 
binding species forms the pool for the next round of 
selection. Repeated selection and amplification steps allow 
identification of the highest binding species, through 
competitive binding. The selection and amplification step 
constitutes one round or cycle in a typical SELEX 
procedure, with anything between 1 and 15 cycles often 
described in the literature. Counter- or negative selection 
steps can ensure that the finally selected aptamers are very 
specific for their target and do not interact with 
homologous proteins or chemically closely-related 
molecular targets (Missailidis, 2008). 
Selected aptamers are subsequently cloned and 
sequenced to identify the sequence of the binding species 
and their interactions are usually characterised by a variety 
of analytical methodologies, prior to move into the various 
applications they were originally destined for. Selected 
aptamer can be easily produced by solid phase synthesis 
and appropriate modifications can be introduced at this 
stage to confer additional properties to the selected 
aptamers, such as nuclease resistance (Figure 2), cross-
linking ability or improved pharmacokinetic properties. 
Although SELEX has been the initial methodology 
associated with aptamer selection and has remained a 
robust and powerful technique, which has been adapted to 
various systems and targets, a number of other 
methodologies have also emerged for the selection of 
aptamers. Such “non-SELEX” based methods for the 
selection of aptamers include capillary electrophoresis 
methodologies (Berezovski et al, 2005; Drabovich et al, 
2005), isolation of aptamers with predefined kinetic and 
thermodynamic properties of their interaction with the 
target, without the need for amplification, allowing the use 
of libraries which are difficult or cannot be amplified, or 
computational methods, which are particularly important 
in selecting aptamers with inhibitory activities or 
sequences that undergo ligand dependent conformational 
changes (Ikebukuro et al, 2005). 
The SELEX procedure and subsequent technologies for 
aptamer selection have offered the tools for the designing 
of aptamers that have found a range of diagnostic 
applications (Khan and Missailidis, 2008). Such 
applications include Photo-SELEX (www.somalogic.com) 
and SELEX NADIR (Winters-Hilt, 2006) using optical 
probe reporting or nanopore reporting mechanisms 
respectively, aptamer microarrays (Cho et al, 2005), 
currently in the market by LC Sciences 
(www.lcsciences.com), fluorescent aptamers in chips and 
microspheres (Potyrailo et al, 1998; Kirby et al, 2004), 
fluorescent sensors for small molecule recognition 
(Yamana et al, 2003; Ozaki et al, 2006), quantum dots 
(Levy et al, 2005; Choi et al, 2006; Ivanovic et al, 2007; 
Liu et al, 2007), colorimetric detection (Liu and Lu, 2004; 
Cho et al, 2006; Liu and Lu, 2006), electrochemical 
detection (Xiao et al, 2005; Mir et al, 2006; Lai et al, 
2007; Papamichael et al, 2007) and piezoelectric quartz 
crystal sensors (Bini et al, 2007). 
The above methods, fluorescent, electrochemical and 
colorimetric detection, have also been used in molecular 
switch type sensors or modular sensor assemblies, where 
the aptamers usually change conformation upon binding to 
either emit a fluorescent signal based on an aptamer 
beacon on sensor, or through non-covalent interaction with 
the fluorescent label, triggering an electrochemical sensor 
or leading to change of colour (Frauendorf and Jaschke, 
2001; Stojanovic et al, 2001; Stojanovic and Landry, 
2002; Stojanovic and Kolpashchikov, 2004; Baker et al, 
2006; Zuo et al, 2007), with particular sensitivities in the 
recognition of small analytes. 
Aptamers have also been used in enzymatic sensing, 
without the use of any label or signal related directly to the 
aptamer. These applications remain based on changes in 
the conformation of bifunctional aptamers that recognise 
the target ligand and an enzyme or ribosome. The binding 
of the aptamer to the ligand results in conformational 
changes that affect enzymatic activity or protein 
expression, and it is the later that is subsequently 
measured (Ogawa and Maeda, 2007; Yoshida et al, 2006; 
Yoshida et al, 2006) or utilises an enzyme to ligate 
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Figure 2. An amino or fluoro modification at the 2’ position of 
the sugar can confer the oligonucleotide aptamer stability against 
nuclease degradation. An alternative to using modifications at the 
2’ of the sugar (whether at the 3’ or 5’ end of the aptamer, or 
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both) for nuclease resistance is to use a flipped base added to the 
end of the aptamer. 
proximally bound aptamers to large protein targets and 
allow their subsequent PCR amplification (Fredriksson et 
al, 2002). 
 
III. Aptamer immobilisation 
Aptamers can certainly be used as molecular 
recognition elements in affinity sensing. The small size of 
aptamers provides advantages over antibodies: (i) a greater 
surface density of receptors and (ii) multiple binding to 
target molecules for sandwich assays. 
The method of immobilization of aptamers to a solid 
support affects the sensitivity of the aptamer to the target 
molecule. Thus, the selected method should maintain the 
binding affinity and selectivity that the aptamers display in 
solution (Balamurugan et al, 2008). 
Aptamers can be attached to the solid support at 
either the 5’-end or the 3’ end. Both positions have been 
reported as being used for aptasensor development. 
However, there are very few studies looking at the effect 
of the two types of end attachment. Recent work suggests 
that it depends on the particular aptamer (Cho et al, 2006), 
although for biological targeting it may be that the 3’ end 
is more suitable, since the 3’ end is the primary target for 
exonucleases, and thus its coupling to the solid support 
would simultaneously confer resistance to nucleases. 
Gold is used for many electrochemical 
measurements. Direct attachment of aptamers to gold 
surfaces could be achieved by using a thiol-alkane linked 
to the aptamer sequence. The gold surface could also be 
functionalized and the type of chemistry selected is 
dependent on what type of terminal functional group is 
linked to the aptamer (amine, thiol or biotin termini; 
Figure 3). 
Gold surfaces functionalized with self-assembled 
monolayers (SAMs) can address the nonspecific 
adsorption of aptamer to the surface, which is a particular 
problem for long oligonucleotides with larger numbers of 
amine groups. Avidin-biotin technology has also been 
exploited for aptamer immobilization. Strepavidin can be 
physically adsorbed or covalently immobilized onto the 
support and the method mainly requires incubation of the 
biotin-tethered aptamer with the modified substrate. 
Studies of the anti-thrombin aptamer revealed this 
biocoating method gives best results regarding sensitivity 
compared to other immobilization strategies (Hianik et al, 
2007). 
 
IV. Electrochemical assays 
In principle, aptamers can be selected for any given 
target, ranging from small molecules to large proteins and 
even cells. When aptamers bind small molecular targets, 
these get incorporated into the nucleic acid structure, 
buried within the binding pockets of aptamer structures. 
On the other hand, large molecules (e.g. proteins) are 
structurally more complicated, allowing aptamer 
interactions at various sites via hydrogen bonding, 
electrostatic interactions and shape complementarity. The 
use of aptamers as bio-recognition elements for small 
molecules has not been reported as extensively as for 
protein targets. 
O
PO O
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CnHS
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O
PO O
O-
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O
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Aptamer
 
 
Figure 3. Standard nucleic acid modifications used for aptamer 
immobilisation. Most of the common modifications are linked 
via the phosphate group of the oligonucleotide aptamer. Various 
lengths carbon chains are used that can offer higher or lower 
flexibility. 
 
Mainly two different assay configurations have been 
reported to transduce these target-binding aptamer events: 
(i) single-site binding and (ii) dual-site binding (Song et al, 
2008). Small molecules are often assayed using the single-
site binding configuration. Protein targets can be assayed 
via both single-site and dual-site binding. The dual-site 
binding assay is commonly known as the sandwich assay. 
Normally, the target molecule is sandwiched between a 
pair of aptamers that bind to different regions of the large 
molecule. One aptamer is immobilized on a suitable solid 
support to capture the target while the other aptamer for 
detection is conjugated to a catalytic label. Enzymes, 
inorganic or organic catalysts or nanoparticles are often 
used for electrochemical detection. In some cases, when 
there is only one aptamer for the molecule of interest, 
antibodies have been reported to be used instead of the 
second aptamer (Ferreira et al, 2008). If the target protein 
contains two identical binding sites, the selection of a 
single aptamer still allows the development of a sandwich 
assay. 
Displacement assays have been also proposed to 
overcome the more challenging detection of small 
molecules. Affinity interactions between aptamers and 
small ligands are weaker than interaction with large 
molecules (with dissociation constants in the µM range, in 
comparison with constants for large molecules that are in 
the pM-nM range). The presence of the small target could 
Gene Therapy and Molecular Biology Vol 13, page 5 
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induce the separation of two strands of a duplex nucleic 
acid (one strand being the aptamer immobilised to a solid 
support). Another strategy could rely on the displacement 
of the aptamer from its complex with the immobilised 
target molecule when the molecule is present in solution 
(De-los-Santos-Alvarez et al, 2008). 
Induced-fit conformational changes of the aptamer 
after binding to the target molecule can also be used to 
monitor a bio-recognition event by tagging the aptamer 
(Figure 4). The use of labels requires precise knowledge 
of the aptamer folding mechanism after binding to the 
target and the binding sites. In the case of a redox active 
marker, the accessibility of the label to the conducting 
support is associated with the tertiary structure of the 
aptamer before and after the binding event. However, for 
small molecules, this strategy is not always viable, 
because the aptamer 3D structure could only be slightly 
perturbed after the ligand interaction. 
Redox-active reporting labels could not be covalently 
tethered to aptamers. Methylene blue has been intercalated 
into the double-stranded DNA domain of a hairpin 
configuration aptamer. The binding of the target with the 
aptamer opens the hairpin structure and releases the 
intercalated methylene blue. As a result, the amperometric 
response decreased with the addition of the analyte. This 
approach is known as “label-free” method (Figure 5). 
 
 
 
Figure 4. Assays based on induced-fit conformational changes of aptamers. 
 
 
 
Figure 5. Label-free electrochemical assays based on: (A) methylene blue intercalated into the DNA aptamer and (B) cationic redox-
active reporting units bound to DNA aptamer phosphate backbone. 
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Related approaches use cationic redox-active reporting 
units bound to the electrode via electrostatic interactions 
with the DNA aptamer phosphate backbone. The binding 
of the target molecule with the aptamer blocked the 
binding of the cationic reporting units and the 
electrochemical response decreased. The main 
disadvantage of these latter approaches is a negative 
detection signal. 
Recently, nanomaterials are also providing novel 
electrochemical sensing approaches. Single-walled carbon 
nanotube field-effect transistor sensors were developed to 
monitor aptamer-protein binding studies. Aptamers are 
well suited for FET sensing due to their small size (1-2 
nm) and recognition occurs inside the electrical double-
layer associated with the gate (within the Debye length). 
The single-walled carbon nanotubes were assembled 
between source and drain electrodes and the aptamers 
were immobilized to these nanomaterials. In this label-free 
approach, the binding of the target molecule to the 
aptamers altered conductance through the device. The ease 
of miniaturization of these sensing devices opens up the 
feasibility of high-throughput assays in microarrays. 
Nanoparticles have also been reported as catalytic 
labels, instead of enzymes, and carriers for ultrasensitive 
electrochemical detection; because one nanoparticle 
contains a large number of aptamers, the target binding 
process is amplified. 
Impedance spectroscopy has been the most 
frequently used electrochemical method in the 
development of electrochemical aptasensors and has 
shown excellent sensitivity, achieving limit of detection of 
fM. However, despite the fact that the analytical technique 
is simple to perform, the data fitting remains a bit 
complicated. Easier data processing and faster response 
could be achieved with chonoamperometry, but the limit 
of detection will be higher and in the nM range. 
 
IV. Applications of electrochemical 
aptasensors 
Aptamer publications have now appeared in the 
literature using most of the electrochemical transducers. 
The majority of aptamer work on electrochemical sensors 
is focused on amperometric transducers, but there have 
been references on aptamers used in impedimetric, FET 
and recently potentiometric sensors. Furthermore, a lot of 
the work on the aptamers in electrochemical sensors has 
been on the model protein, thrombin, which is one of the 
best characterised complexes in the aptamer literature. 
These have provided proof of principle concepts as to how 
aptamers could be developed in novel sensors. However, a 
number of other systems have also now been described, 
which will be presented in this review. 
 
A. Electrochemical aptasensors for the model 
protein 
The thrombin-binding aptamer (15-mer, 5’-
GGTTGGTGTGGTTGG-3’) was the first one selected in 
1992 by Block and colleagues and its structure has been 
well characterized and studied. The folded structure in 
solution is composed of two guanine quartets connected 
by two T-T loops spanning the narrow grooves at one end 
and a T-G-T loop spanning a wide groove at the other end 
(known as the G-quartet structure). This anti-thrombin 
aptamer has been extensively used as the model 
oligonucleotide by many researchers to demonstrate the 
wide applicability of aptamers as bio-recognition elements 
in biosensors. 
In the literature, many different electrochemical 
aptasensors for thrombin detection have been reported. 
The most straightforward configuration is based on the 
immobilization of a thiol terminated aptamer on a gold 
electrode. The aptamer-thrombin interaction is transduced 
by the electrochemical quantification of p-nitroaniline 
produced by the thrombin’s enzymatic reaction. Thrombin 
has two electropositive exosites both capable of binding 
the aptamer, allowing the development of an 
electrochemical sensor system in a sandwich manner. The 
thiolated aptamer was immobilized on a gold electrode 
and, after incubation with the thrombin, a second 
incubation step with an HRP labelled aptamer took place. 
Electrochemical detection of HRP was performed using 
H2O2 and a diffusional osmium based mediator. A similar 
aptasensor system in sandwich manner for thrombin was 
developed based on the aptamer for detection, labelled 
with pyrroquinoline quinine glucose dehydrogenase, and 
the electric current generated from glucose addition after 
the formation of the complex on a gold electrode 
(Ikebukuro et al, 2005). Another strategy for the thrombin 
sensing is the direct immobilization of the protein on the 
electrode surface. After the incubation with biotin-labelled 
aptamer and then with streptavidin-HRP, the 
electrochemical detection is performed using H2O2 and a 
diffusional osmium-based mediator. The latter approach 
achieved the lower limit of detection, 3.5 nM (Mir et al, 
2006). 
Mir and colleagues also developed in 2008 a 
chronoamperometric beacon biosensor based on a 
ferrocene-labelled thiol-aptamer. The aptamer adopts a 3-
D conformational change after binding the thrombin, 
allowing the ferrocene label to approach to the gold 
electrode. The interaction is detected via a 
microperoxidase mediated electron transfer between the 
label and the electrode surface. The system was 
demonstrated with impedance spectroscopy and 
chronoamperometry measurements, achieving a limit of 
detection of 30 fM with the impedance spectroscopy (Mir 
et al, 2008). 
Methylene blue has also been used as an 
electrochemical marker. The beacon aptamer surface was 
prepared following formation of 11-mercaptoundecanoic 
acid self-assembled monolayer on gold electrode. 
Methylene blue was intercalated on the aptamer by the 
interaction with two guanine bases. Binding of the 
thrombin is correlated with the decrease in electrical 
current intensity in voltammetry. The estimated detection 
limit of the target thrombin was 11 nM (Bang et al, 2005). 
The modification of antibodies is difficult, costly and 
time consuming; however researchers have been using 
conventional polyclonal antibodies as a capturing probe 
and labelled-aptamers as the detection probe in new 
sandwich approaches for protein detection. Kang and 
Gene Therapy and Molecular Biology Vol 13, page 7 
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colleagues reported in 2008 a modified electrochemical 
sandwich model for thrombin, based on capturing 
antibody immobilized onto glassy carbon electrodes with 
nanogold-chitosan composite film and Methylene blue 
labelled aptamer as the electrochemical detection probe. 
Lu and colleagues described in 2008 an 
electrochemical aptasensor for thrombin that is not based 
on the target binding-induced conformational change of 
aptamers. The thrombin-binding aptamer is first assembled 
onto a gold electrode and then hybridized with a ferrocene 
labelled short aptamer-complementary DNA 
oligonucleotide. The binding of the thrombin to the 
aptamer destroys the double-stranded DNA 
oligonucleotide and leads to the dissociation of the label 
short complementary DNA oligonucleotide from the 
electrode surface, resulting in a decrease in the differential 
pulse voltammetry responses at the electrode (Lu et al, 
2008). This strategy is based on the stronger binding 
affinity of the aptamers towards their targets rather than to 
the short aptamer-complementary DNA oligonucleotide 
labelled with electroactive moieties. 
The majority of the work performed on aptamer-
based electrochemical biosensors is based on aptamers 
labelled using redox compounds, such as methylene blue, 
and catalysts such as horseradish peroxidase. However, 
nanoparticle-based materials offer excellent prospects for 
a new signal amplification strategy for ultrasensitive 
electrochemical aptasensing. Platinum nanoparticles have 
been reported as catalytic labels when linked to a thiolated 
aptamer. The nanoparticles catalysed the electrochemical 
reduction of H2O2 and the resulting current enabled the 
amplified detection of thrombin sandwiched between the 
aptamer on the electrode surface and the aptamer labelled 
with the nanoparticles (Polsky et al, 2006). Gold 
nanoparticles offer several advantages such as electrical 
conductivity, biocompatibility, ease of self-assembly 
through a thiol group, increase electrode surface area and 
amount of immobilized capturing probe. Gold 
nanoparticles have been used as an electrochemical 
sensing platform for direct detection of thrombine. The 
aptamer was immobilised on a screen-printed electrode 
modified with gold-nanoparticles by avidin-biotin 
technology. The gold-nanoparticles surface status is 
evaluated by the Au/Au oxide film formation with cyclic 
and stripping voltammetry. Gold nanoparticles signal 
changed with the deposition of biolayers due to 
differences in electron transfer efficacy and availability of 
buffer oxygen. Aptamers prefer to adopt the G-quarter 
structure when binding with thrombin and the 
conformational changes made double strand DNA zones 
appear and facilitated the electron transfer from solution to 
the electrode surface, based on the double stranded DNA’s 
ability to transport charge along the nucleotide stacking 
(Suprun et al, 2008). The detection limit of this novel 
approach is in the nM range. However, the aptasensor 
measured directly binding events and opened 4 orders of 
magnitude the operating range of protein concentration. 
Assays coupling aptamers with magnetic beads for 
the aptamer or target immobilisation before the 
electrochemical transduction have also been proposed 
(Centi et al, 2008). The use of magnetic beads improved 
the assay kinetics due to the beads being in suspension and 
also minimized matrix effect because of better washing 
and separation steps. 
An ultrasensitive electrochemical aptasensor for 
thrombin in a sandwich format of magnetic nanoparicle-
immobilized aptamer, thrombin and gold nanoparticle-
labelled aptamer was reported by Zheng and colleagues in 
2007. The magnetic nanoparticle-immobilized aptamer 
was used for capturing and separating the target protein. 
The gold nanoparticle-labelled aptamer offered the 
electrochemical signal transduction. The signal was 
amplified by forming a network like thiocyanuric acid/ 
gold nanoparticles to cap more nanoparticles per assay, 
lowering the detection limit to the aM range 
 
B. Other targets 
Aptamer have been selected against a wide range of 
targets with typical binding affinities in the nanomolar to 
picomolar range. Recently, electrochemical aptasensors 
have been reported to detect proteins, hormones and drugs. 
Papamichael and colleagues described in 2007 a 
disposable electrochemical aptasensor for 
Immunoglobulin E, a key marker of atopic diseases (such 
as asthma, dermatitis and pollenosis). The sensor 
incorporates a competitive format for IgE detection using 
a biotinylated form of the aptamer. A standard, indirect 
method was used where competition between surface-
bound IgE and IgE in solution proceeded for the aptamer. 
The electrochemical detection is achieved by the use of an 
extravidin-alkaline phosphatase label. After careful 
optimization of conditions (buffer pH, ionic strength, 
additional ions and proteins), the aptasensor was 
performing at levels suitable for human testing (>300ng 
ml-1). 
Platelet-derived growth factor BB (PDGF-BB) is one 
important cytokine involved in neural inflammation and 
was selected as target for the development of an 
electrochemical aptasensor based on capacitance change 
induced by aptamer-protein specific binding, measured by 
non-faradic impedance spectroscopy. The biosensor 
detection limit was 40 nM. Electrochemical impedance 
spectroscopy is a very attractive method for in vivo 
diagnostics, due to its high sensitivity and label free 
characteristics (Liao and Cui, 2007). A similar 
electrochemical detection was also reported to a 
tuberculosis-related cytokine, the interferon-!. The 
aptamer-based electrochemical impedance biosensor 
successfully detected interferon-! to a level of 100 fM 
with an RNA aptamer and 1 pM with a DNA aptamer 
probe (Min et al, 2008). 
Electrochemical aptasensors for 17-" estradiol have 
also been reported. The selected biotinylated DNA 
aptamer was immobilized on a streptavidin-modified gold 
electrode. The chemical binding of the hormone to the 
aptamer was monitored by cyclic and square wave 
voltammetry. When the 17-" estradiol interacted with the 
aptamer, the current decreased due to the interference of 
the bound target molecule with the electron flow produced 
by a redox reaction between ferrocyanide (the mediator) 
and ferricyanide. The linear range of this aptasensing 
device was 1-0.01 nM of 17-" estradiol (Kim et al, 2007). 
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Cocaine has been detected by an electrochemical 
aptasensor incorporating gold nanoparticles onto the 
surface of a gold electrode. The thiol-derivative aptamer 
was self-assembled onto the gold nanoparticles. The 
aptamer was also functionalized at the other termini of the 
strand with a redox-active ferrocene moiety. The cocaine 
binding to the aptamer induces the conformational change 
of the aptamer, bringing the redox tag in close proximity 
to the electrode, leading to an increase in the current (Li et 
al, 2008). Methylene blue tagged aptamer has been also 
explored for the detection of cocaine (Baker et al, 2006). 
A novel adenosine aptasensor was reported based on 
the structure change of an aptamer probe immobilized on a 
gold electrode. After the binding aptamer-target 
nucleoside, a higher surface charge density and an 
increasing steric hindrance were obtained that reduce the 
diffusion of [Fe(CN)6]
3-/[Fe(CN)6]
4- towards the electrode 
surface, resulting in a decrease of the current. The 
biosensing surface was easily regenerated and the 
aptasensor limit of detection was 10 nM (Zheng et al, 
2008). 
 
C. Aptasensor arrays 
Some of the aptamer-based biosensor technology 
described in this review could be transferred from single-
analyte devices to electrochemical methods offering the 
possibility of simultaneous measurements of a panel of 
targets. Wang reviewed the use of metal nanoparticles as 
tracers for the analysis of nucleic acid hybridization. 
Magnetic nanoparticles were linked to different probe 
DNAs and incubated with samples containing different 
DNA targets. Semiconductor quantum dots were 
functionalized each with different nucleic acids 
complementary to the free chain of the target DNA. After 
dissolution of the metal nanoparticles, the identification of 
the metal ions by stripping voltammetry enabled the 
analysis of the different DNA targets (Wang, 2003). 
Thrombin and lysozyme were detected in parallel 
using a competitive assay in which thrombin and 
lysozyme were modified with different semiconductor 
quantum dots (Hansen et al, 2006). Specific aptamers were 
immobilized on a gold electrode and bound to the 
respective labelled protein. In the presence of unlabelled 
protein in the sample, the quantum-dot functionalized 
protein is displaced from the electrode into solution. The 
dissolution of the remaining metal ions on the surface and 
the electrochemical detection of the released ions enabled 
the quantitative detection of the proteins. 
 
IV. Conclusions 
Aptamers have been widely used in a variety of 
diagnostic and sensor applications, offering a variety of 
possibilities for aptamer-based sensors in early disease 
diagnosis and prognosis, substance control, environmental 
measurements or national security applications on 
measurements of explosives or potential infectious agents. 
Yet, despite the advances and the huge body of literature 
documenting the success of the technology, the 
commercial application of aptamers in the field of 
diagnostics remains relatively undeveloped, not least due 
to the exclusive IP portfolio, and the fact that there is a 
vast antibody-based diagnostic market and a certain degree 
of hesitation to move to a new type of product, unless 
aptamers offer verifiably significant improvements on 
current technologies that warrant substitution of antibodies 
in some current assay formats. In this review, different 
types of electrochemical aptamer-based biosensors have 
been discussed. Although the optical and mass-sensitive 
aptasensors have been the most commonly described in 
the literature, electrochemical transducers have enormous 
potential and offer simple, rapid, cost-effective and easy to 
miniaturize sensing in many diagnostic fields. Emerging 
nanomaterials have also brought new possibilities for 
developing novel ultrasensitive electrochemical 
aptasensors. 
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